Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017Acute Pain Therapeutics Market is Forecast to Show Low Growth until 2017
By: Globaldata For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ GlobalData’s research indicates that the acute pain pipeline is weak with molecules in various phases of clinical development. The first-in-class molecules seem to have distinct advantages over the current products in terms of better disease management. Although the unmet need of the acute pain market is low and the treatment relies on older therapies and drugs, the market needs novel therapies offering better results in terms of safety and efficacy. AcelRX Pharmaceuticals, Inc., Acura Pharmaceuticals, Inc /King Pharmaceuticals, Cara Therapeutics, GlaxosmithKline, Grunenthal GMBH, QRX Pharma, Transdel Pharmaceuticals, Inc. and Xenome Ltd. are going to be the key players in future. GlobalData has profiles of all these companies as they hold important pipeline drugs in late stage development for acute pain. The existing market landscape remains competitive, because the treatment of acute pain relies on established, older therapies like non-steroidal anti-inflammatory drugs (NSAIDS), opioids, and Cyclooxygenase- GlobalData analysis shows that the acute pain therapeutics pipeline is weak, with 21 molecules in various phases of clinical development, including six first-in-class molecules. These first-in-class molecules are in the early stage of clinical development, so their impact on the market will be on the later stage. In the case of acute pain therapeutics, most of the late stage pipeline does not have a novel mechanism of action. Thus the pipeline for the acute pain therapeutics market is weak. GlobalData has released its new report, “Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global acute pain market. The report identifies the key trends shaping and driving the global acute pain market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global acute pain sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. End
|
| ||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number